Steve Brozak is the Managing Partner and President of WBB Securities, LLC. In 2013, Dr. Brozak was selected as a top analyst in the pharmaceuticals sector by the StarMine/Financial Times Industry Analyst Awards. He also was named to The Wall Street Journal’s “Best on the Street” list in the category of medical equipment and supplies. Earlier, Dr. Brozak worked in finance at Alex. Brown & Sons, Cowen & Company, Dean Witter and Salomon Brothers. Dr. Brozak has written for Nature, The British Medical Journal and Brain Stimulation. He is also a contributor to Forbes and ABC News. He received a B.A. degree and an MBA from Columbia University and a Doctorate in Medical Humanities — DMH — from Drew University. He served in the United States Marine Corps retiring as a lieutenant colonel.
Early-Stage Anti-Inflammatory Drugs May Provide Breakthrough Treatments
September 30, 2021
Critical Demand for Innovation in Pharma and Biotech
August 12, 2016
A Health Care Convergence of Biotech, Pharma and Medical Devices
February 21, 2014